- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Dividend Powerhouses (3%+ Yield)
Taiwanese Pharmaceuticals & Biotech Dividend Powerhouses (3%+ Yield)
Results
6
This screener pinpoints dividend all-stars that boast strong fundamentals with yields typically exceeding 3%.
6 companies
PharmaEngine
Market Cap: NT$12.6b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$87.60
7D
-3.0%
1Y
-3.8%
Standard Chemical & Pharmaceutical
Market Cap: NT$10.3b
Standard Chemical & Pharmaceutical Co. Ltd.
1720
NT$57.70
7D
-1.5%
1Y
-17.7%
TTY Biopharm
Market Cap: NT$18.9b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$75.90
7D
0.9%
1Y
-1.9%
SYN-TECH Chem. & Pharm
Market Cap: NT$4.0b
Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.
1777
NT$89.20
7D
0%
1Y
-1.1%
YungShin Global Holding
Market Cap: NT$16.4b
Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.
3705
NT$61.40
7D
0.2%
1Y
12.2%
Sinphar PharmaceuticalLtd
Market Cap: NT$5.9b
Engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.
1734
NT$32.55
7D
-1.4%
1Y
-4.9%